These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9027989)

  • 21. Extended binding site of ricin B lectin for oligosaccharide recognition.
    Ganguly D; Mukhopadhyay C
    Biopolymers; 2007 Jul; 86(4):311-20. PubMed ID: 17450571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure of recombinant ricin A chain at 2.3 A.
    Mlsna D; Monzingo AF; Katzin BJ; Ernst S; Robertus JD
    Protein Sci; 1993 Mar; 2(3):429-35. PubMed ID: 8453380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved antibody-based ricin neutralization by affinity maturation is correlated with slower off-rate values.
    Rosenfeld R; Alcalay R; Mechaly A; Lapidoth G; Epstein E; Kronman C; J Fleishman S; Mazor O
    Protein Eng Des Sel; 2017 Sep; 30(9):611-617. PubMed ID: 28472478
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ricin A-chain: kinetics, mechanism, and RNA stem-loop inhibitors.
    Chen XY; Link TM; Schramm VL
    Biochemistry; 1998 Aug; 37(33):11605-13. PubMed ID: 9708998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computational approaches for identification of conserved/unique binding pockets in the A chain of ricin.
    Zhou CL; Zemla AT; Roe D; Young M; Lam M; Schoeniger JS; Balhorn R
    Bioinformatics; 2005 Jul; 21(14):3089-96. PubMed ID: 15905278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition and interaction of small rings with the ricin A-chain binding site.
    Yan X; Day P; Hollis T; Monzingo AF; Schelp E; Robertus JD; Milne GW; Wang S
    Proteins; 1998 Apr; 31(1):33-41. PubMed ID: 9552157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small-molecule inhibitors of ricin and Shiga toxins.
    Wahome PG; Robertus JD; Mantis NJ
    Curr Top Microbiol Immunol; 2012; 357():179-207. PubMed ID: 22006183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pterin-based small molecule inhibitor capable of binding to the secondary pocket in the active site of ricin-toxin A chain.
    Saito R; Goto M; Katakura S; Ohba T; Kawata R; Nagatsu K; Higashi S; Kurisu K; Matsumoto K; Ohtsuka K
    PLoS One; 2022; 17(12):e0277770. PubMed ID: 36508422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circular DNA and DNA/RNA hybrid molecules as scaffolds for ricin inhibitor design.
    Sturm MB; Roday S; Schramm VL
    J Am Chem Soc; 2007 May; 129(17):5544-50. PubMed ID: 17417841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. X-ray structure of recombinant ricin A-chain at 1.8 A resolution.
    Weston SA; Tucker AD; Thatcher DR; Derbyshire DJ; Pauptit RA
    J Mol Biol; 1994 Dec; 244(4):410-22. PubMed ID: 7990130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of ricin A-chain at 2.5 A.
    Katzin BJ; Collins EJ; Robertus JD
    Proteins; 1991; 10(3):251-9. PubMed ID: 1881881
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crystallographic refinement of ricin to 2.5 A.
    Rutenber E; Katzin BJ; Ernst S; Collins EJ; Mlsna D; Ready MP; Robertus JD
    Proteins; 1991; 10(3):240-50. PubMed ID: 1881880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ricin A-chain substrate specificity in RNA, DNA, and hybrid stem-loop structures.
    Amukele TK; Schramm VL
    Biochemistry; 2004 May; 43(17):4913-22. PubMed ID: 15109249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Using homology modeling to interrogate binding affinity in neutralization of ricin toxin by a family of single domain antibodies.
    Bazzoli A; Vance DJ; Rudolph MJ; Rong Y; Angalakurthi SK; Toth RT; Middaugh CR; Volkin DB; Weis DD; Karanicolas J; Mantis NJ
    Proteins; 2017 Nov; 85(11):1994-2008. PubMed ID: 28718923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vinyldeoxyadenosine in a sarcin-ricin RNA loop and its binding to ricin toxin a-chain.
    Roday S; Saen-oon S; Schramm VL
    Biochemistry; 2007 May; 46(21):6169-82. PubMed ID: 17477546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ricin vaccine development.
    Smallshaw JE; Vitetta ES
    Curr Top Microbiol Immunol; 2012; 357():259-72. PubMed ID: 21805396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Galactose-induced dimerization of blocked ricin at acidic pH: evidence for a third galactose-binding site in ricin B-chain.
    Venkatesh YP; Lambert JM
    Glycobiology; 1997 Apr; 7(3):329-35. PubMed ID: 9147041
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An in vitro evaluation of epigallocatechin gallate (eGCG) as a biocompatible inhibitor of ricin toxin.
    Dyer PD; Kotha AK; Gollings AS; Shorter SA; Shepherd TR; Pettit MW; Alexander BD; Getti GT; El-Daher S; Baillie L; Richardson SC
    Biochim Biophys Acta; 2016 Jul; 1860(7):1541-50. PubMed ID: 27017946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ribosomal RNA identity elements for ricin and for alpha-sarcin: mutations in the putative CG pair that closes a GAGA tetraloop.
    Glück A; Endo Y; Wool IG
    Nucleic Acids Res; 1994 Feb; 22(3):321-4. PubMed ID: 8127668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of a ricin mutant showing rescue of activity by a noncatalytic residue.
    Kim Y; Mlsna D; Monzingo AF; Ready MP; Frankel A; Robertus JD
    Biochemistry; 1992 Mar; 31(12):3294-6. PubMed ID: 1348187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.